INDIANAPOLIS--(BUSINESS WIRE)--Positron Corporation (OTCBB:POSC) a molecular imaging solutions company focused on Nuclear Cardiology, announced today that the Nuclear Regulatory Commission has licensed the Positron facility in Fishers, Indiana to handle radioactive material. Positron Corporation and staff demonstrated the necessary expertise and protocol to receive this license. A radioactive material handling license allows Positron to test equipment and develop new technologies, including pharmaceuticals. “A radioactive material license directly benefits our current product line and increases our ability to deliver new technologies,” stated John A. Zehner, Positron Corporation, COO and Radiation Safety Officer. “The ability to handle radioactive material will enhance our sales efforts, allow new revenue streams, as well as, offer new opportunities to partner with pharmaceutical companies, Government agencies, inventors and universities.”
